Objective Physiologic Measures Characterize Treatable Disease Meet VIP Finally, a proven answer
2010 (113 Slides)
Ritchie C. Shoemaker, MD
This VIP talk is the first discussion of the successful outcome of the IRB-approved study of VIP in those with CFS.
- You will receive a .pdf file via email within 24 hours of placing your order.